Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,807,000 | 3,750,000 | 3,843,000 | 2,470,000 | 2,560,000 |
| Depreciation Amortization | 1,133,000 | 1,132,000 | 891,000 | 912,000 | 907,900 |
| Income taxes - deferred | 81,000 | 91,000 | -1,272,000 | 127,000 | -65,900 |
| Accounts receivable | -1,053,000 | -695,000 | -22,000 | -1,381,000 | -42,900 |
| Accounts payable and accrued liabilities | 1,826,000 | -1,059,000 | 732,000 | 322,000 | 193,000 |
| Other Working Capital | -94,000 | -1,578,000 | 368,000 | -510,000 | 823,100 |
| Other Operating Activity | -639,000 | 2,186,000 | -355,000 | 1,330,000 | -163,300 |
| Operating Cash Flow | $6,061,000 | $3,827,000 | $4,185,000 | $3,270,000 | $4,211,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 254,000 | -149,000 | 625,000 | 222,000 | 214,400 |
| PPE Investments | -1,077,000 | -1,208,000 | -791,000 | -584,000 | -602,900 |
| Net Acquisitions | N/A | -1,760,000 | -2,080,000 | 8,636,000 | -638,900 |
| Purchase Of Investment | -22,954,000 | -9,671,000 | -16,375,000 | -12,067,000 | -11,859,200 |
| Sale Of Investment | 21,035,000 | 11,600,000 | 13,462,000 | 3,317,000 | 11,779,800 |
| Other Investing Activity | -50,000 | -71,000 | 77,000 | -38,000 | -44,700 |
| Investing Cash Flow | $-2,792,000 | $-1,259,000 | $-5,082,000 | $-514,000 | $-1,151,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,336,000 | 9,270,000 | 5,281,000 | 2,691,000 | 2,301,800 |
| Debt Issued | 2,176,000 | 835,000 | 5,633,000 | -53,000 | 1,908,700 |
| Debt Repayment | -9,158,000 | -1,791,000 | -2,815,000 | N/A | -2,697,200 |
| Common Stock Issued | 187,000 | 1,423,000 | 226,000 | 120,000 | 202,600 |
| Common Stock Repurchased | -1,701,000 | -1,685,000 | -1,998,000 | N/A | -1,515,800 |
| Dividend Paid | -818,000 | -776,000 | -705,000 | -684,000 | -656,600 |
| Other Financing Activity | -288,000 | -9,517,000 | -5,195,000 | -2,873,000 | -2,636,800 |
| Financing Cash Flow | $-2,266,000 | $-2,241,000 | $427,000 | $-799,000 | $-3,093,300 |
| Exchange Rate Effect | 0 | -2,000 | 4,000 | 5,000 | -5,300 |
| Beginning Cash Position | 3,934,000 | 3,609,000 | 4,075,000 | 2,113,000 | 2,151,700 |
| End Cash Position | 4,937,000 | 3,934,000 | 3,609,000 | 4,075,000 | 2,113,500 |
| Net Cash Flow | $1,003,000 | $325,000 | $-466,000 | $1,962,000 | $-38,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,061,000 | 3,827,000 | 4,185,000 | 3,270,000 | 4,211,900 |
| Capital Expenditure | -1,077,000 | -1,208,000 | -791,000 | -584,000 | -638,200 |
| Free Cash Flow | 4,984,000 | 2,619,000 | 3,394,000 | 2,686,000 | 3,573,700 |